Characterization of bromodeoxyuridine-induced guinea pig type B retravirus.
D000818:Animals; D000956:Antigens, Viral / Q000032:analysis; D001973:Bromodeoxyuridine / Q000494:pharmacology; D002478:Cells, Cultured; D003907:Dexamethasone / Q000494:pharmacology; D004357:Drug Synergism; D004789:Enzyme Activation / Q000187:drug effects; D004790:Enzyme Induction / Q000187:drug effects; D006168:Guinea Pigs / Q000382:microbiology*; D008274:Magnesium / Q000494:pharmacology; D008345:Manganese / Q000494:pharmacology; D009858:Oncogenic Viruses / Q000201:enzymology / Q000254:growth & development* / Q000276:immunology; D012328:RNA Viruses / Q000201:enzymology / Q000254:growth & development* / Q000276:immunology; D012194:RNA-Directed DNA Polymerase / Q000378:metabolism*; D013698:Templates, Genetic; D014779:Virus Replication / Q000187:drug effects
D000956:Antigens, Viral; D008345:Manganese; D003907:Dexamethasone; D012194:RNA-Directed DNA Polymerase; D001973:Bromodeoxyuridine; D008274:Magnesium